HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.650
-0.120 (-3.18%)
Jan 6, 2025, 4:00 PM EST - Market closed

HeartSciences Revenue

HeartSciences had revenue of $14.70K in the twelve months ending October 31, 2024, up 151.28% year-over-year. In the fiscal year ending April 30, 2024, HeartSciences had annual revenue of $18.60K with 261.17% growth.

Revenue (ttm)
$14.70K
Revenue Growth
+151.28%
P/S Ratio
180.07
Revenue / Employee
$980
Employees
15
Market Cap
3.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202418.60K13.45K261.17%
Apr 30, 20235.15K-9.22K-64.17%
Apr 30, 202214.37K-11.23K-43.86%
Apr 30, 202125.60K-38.58K-60.11%
Apr 30, 202064.18K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 393.90B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings